Russell Investments Group Ltd. increased its position in shares of Crocs, Inc. (NASDAQ:CROX - Free Report) by 57.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,172 shares of the textile maker's stock after acquiring an additional 9,942 shares during the period. Russell Investments Group Ltd.'s holdings in Crocs were worth $2,976,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in shares of Crocs by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 5,477,574 shares of the textile maker's stock worth $599,959,000 after purchasing an additional 47,576 shares during the last quarter. Empowered Funds LLC grew its position in Crocs by 42.0% in the fourth quarter. Empowered Funds LLC now owns 77,152 shares of the textile maker's stock worth $8,450,000 after buying an additional 22,809 shares during the last quarter. State of Alaska Department of Revenue increased its holdings in shares of Crocs by 129.8% in the fourth quarter. State of Alaska Department of Revenue now owns 21,678 shares of the textile maker's stock valued at $2,373,000 after buying an additional 12,245 shares in the last quarter. Impax Asset Management Group plc acquired a new stake in shares of Crocs during the 4th quarter valued at $684,000. Finally, Oppenheimer & Co. Inc. boosted its stake in shares of Crocs by 39.3% during the 4th quarter. Oppenheimer & Co. Inc. now owns 17,236 shares of the textile maker's stock worth $1,888,000 after acquiring an additional 4,862 shares in the last quarter. 93.44% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other Crocs news, EVP Adam Michaels sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $106.69, for a total transaction of $1,600,350.00. Following the completion of the sale, the executive vice president now owns 89,323 shares of the company's stock, valued at $9,529,870.87. This represents a 14.38 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Shannon Sisler sold 4,659 shares of the stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $109.75, for a total value of $511,325.25. Following the transaction, the executive vice president now owns 29,299 shares in the company, valued at approximately $3,215,565.25. This trade represents a 13.72 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.72% of the company's stock.
Crocs Stock Up 5.0 %
Shares of CROX traded up $4.67 during midday trading on Wednesday, reaching $98.26. 517,917 shares of the stock were exchanged, compared to its average volume of 1,457,317. The company has a market cap of $5.51 billion, a price-to-earnings ratio of 6.15, a P/E/G ratio of 1.80 and a beta of 1.62. The firm has a 50 day simple moving average of $101.30 and a 200-day simple moving average of $107.37. Crocs, Inc. has a 12-month low of $86.11 and a 12-month high of $165.32. The company has a quick ratio of 0.70, a current ratio of 1.18 and a debt-to-equity ratio of 0.74.
Crocs (NASDAQ:CROX - Get Free Report) last posted its earnings results on Thursday, February 13th. The textile maker reported $2.52 EPS for the quarter, topping the consensus estimate of $2.27 by $0.25. Crocs had a net margin of 23.16% and a return on equity of 46.27%. Research analysts forecast that Crocs, Inc. will post 13.2 EPS for the current year.
Analysts Set New Price Targets
CROX has been the subject of several analyst reports. Robert W. Baird reduced their target price on Crocs from $180.00 to $150.00 and set an "outperform" rating for the company in a report on Monday, February 10th. Loop Capital upped their price objective on shares of Crocs from $110.00 to $125.00 and gave the company a "buy" rating in a research note on Tuesday, April 1st. Bank of America lifted their target price on shares of Crocs from $144.00 to $153.00 and gave the stock a "buy" rating in a research report on Friday, February 14th. Piper Sandler reduced their price target on shares of Crocs from $125.00 to $115.00 and set an "overweight" rating for the company in a research report on Friday, April 11th. Finally, UBS Group raised their price objective on shares of Crocs from $122.00 to $132.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 19th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, Crocs presently has a consensus rating of "Moderate Buy" and an average price target of $140.00.
Get Our Latest Stock Analysis on Crocs
Crocs Profile
(
Free Report)
Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.
Further Reading

Before you consider Crocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crocs wasn't on the list.
While Crocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report